Business - Briefly   

Advinus Therapeutics, DNDi join forces

BANGALORE: Advinus Therapeutics (P) Ltd. and Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R&D organisation based in Geneva, Switzerland, announced on Thursday the formation of a collaboration for the discovery and development of novel therapies for visceral leishmaniasis (kala azar), a fatal infectious disease in developing countries, including India, says a release. — Staff Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Infosys revenues cross $1 b in Q2
Sensex heading towards 19000
Birla-Lodha case: single bench order set aside
India can achieve 10-11 p.c. GDP growth: ADB chief
GE to focus more on wind, solar energy
South Indian Bank’s net up
SumTotal offers enterprise solution
Fiat, Tata Motors form industrial joint venture
UAE firm keen to enter India
‘E-platform offers better price realisation in rubber futures’
Amul may acquire stake in Vanilco
Rupee remains firm
Exchange Rates
Bullion Rates
Corporation Bank’s cash back offer
Advinus Therapeutics, DNDi join forces
Locuz, Choice merge to form a new entity
Sundaram Industries in JV with Novotema
Sobha forms venture with Australian co.
U.S. govt. accedes to steel makers’ request
ICICI Bank cuts home loan rates
GM offers discount on Chevy Spark
Airtel chooses Israeli firm for IPTV services
L&T buys Malaysian co.

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu